Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series

BACKGROUND: A novel antiviral agent, remdesivir (RDV), is a promising candidate treatment for coronavirus disease 2019 (COVID-19) in the absence of any proven therapy. MATERIALS AND METHODS: This retrospective case series included 10 patients with a clinically and laboratory confirmed diagnosis of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Choongman, Ahn, Mi Young, Byeon, Kyeongmin, Choi, Jae-Phil, Hahm, Chorom, Kim, Hyeonmok, Kim, Suhyun, Kim, Tae Ho, Oh, JungKyun, Oh, Dong Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533211/
https://www.ncbi.nlm.nih.gov/pubmed/32757500
http://dx.doi.org/10.3947/ic.2020.52.3.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533211/
https://www.ncbi.nlm.nih.gov/pubmed/32757500
http://dx.doi.org/10.3947/ic.2020.52.3.369

Ejemplares similares